Cytokinetics Announces Initiation of First-Time-in-Humans, Phase I Clinical Trial of CK-2127107

[at noodls] – Second Drug Candidate from Cytokinetics’ Fast Skeletal Muscle Activator Program Begins Clinical Trial in Expanded Development Program South San Francisco, CA – April 1, 2013 Cytokinetics, Incorporated … more

View todays social media effects on CYTK

View the latest stocks trending across Twitter. Click to view dashboard

See who Cytokinetics is hiring next, click here to view